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Summary 
The interaction of the T cell surface glycoprotein CD8 with major histocompatibility complex 
(MHC) class I molecules on target cells is required for effective T  cell activation. Mutations 
in the or3 domain of the MHC class I molecule can disrupt binding to CD8, yet leave antigen 
presentation unaffected. Here we show that such a mutation can interfere with positive and negative 
sdection of T  cells beating T  cell receptors (TCKs) that interact specifically with the mutant 
class I molecule. Autoreactive T cells in male mice expressing a transgenic TCK specific for the 
male antigen H-Y  and H-2D  b were not deleted in the context of a transgenic D b molecule 
bearing a mutation at residue 227. Similarly, CD8 + cells were not positively selected in female 
mice expressing both the TCK and mutant class I transgenes. Endogenous MHC class I molecules 
were competent to bind CD8, but were unable to rescue the defect, indicating a requirement 
for coordinate recognition of antigen/MHC by a complex of the TCK and CD8 coreceptor 
for both positive and negative selection of thymocytes. 
T 
he repertoire of T lymphocytes is determined by inter- 
actions of immature thymocytes with MHC molecules 
in the thymus. Maturation involves positive selection of cells 
with oe3 TCKs specific for host MHC molecules and elimi- 
nation of cells that react with self-antigen complexed to the 
same MHC molecules (1). The mechanisms permitting thymo- 
cytes to discriminate between self and non-self, and to trans- 
duce signals tailored to the nature of the antigen, are not 
understood. The signals clearly involve the TCR complex, 
which consists of the clonotypic oe and B chains and several 
associated polypeptides (2). In addition, other thymocyte sur- 
face molecules, most notably the CD4 and CD8 glycopro- 
teins, have been implicated as having important roles in the 
signal transduction (3, 4).  CD4 and CD8 are coexpressed 
on most immature thymocytes, but mature T  cells express 
one to the exclusion of the other. The expression  of CD4 
and CD8 correlates with the function and the MHC specificity 
of T  cells. Cells with TCRs specific for antigen bound to 
class II MHC molecules are primarily helper cells and ex- 
press CD4, while cells with receptors specific for antigen and 
class I MHC molecules have cytotoxic function and express 
CD8 (5,  6). 
The extracellular domains of CD4 and CD8 bind to non- 
polymorphic domains of class II and class I MHC molecules, 
respectively (7-9), while their cytoplasmic domains bind to 
a cytoplasmic tyrosine kinase, p56  ~k (10-12).  Effective acti- 
vation of T cells requires that CD4 and CD8 bind both the 
MHC on the antigen-presenting cells and the tyrosine ki- 
nase on the cytoplasmic side of the plasma membrane (13, 
14). Several studies have suggested that T cell activation results 
from simultaneous engagement of the same MHC molecule 
by the TCK and CD4/CD8, with consequent bridging of 
p56  ~k and TCK-associated  polypeptides (15, 16). It has thus 
been proposed that CD4 and CD8 function as coreceptors, 
contributing to signal transduction through the TCR (17). 
Several studies have provided evidence that the CD4 and 
CD8 molecules have important functions during thymocyte 
development. Injection of anti-CD4 or -CD8 mAbs block 
the development of class II or class I-specific  T  cells, sug- 
gesting that these molecules have an important role in posi- 
tive selection (18, 19). This conclusion is supported by the 
finding that mice beating null mutations in the CD8c~ or 
CD4 gene have significant  impairment in the development 
of T  cells with the appropriate MHC restriction and with 
cytotoxic or helper function, respectively (20, 21). Treatment 
with anti-CD4 antibody also prevents the deletion of double 
positive T cells bearing self-superantigen-reactive TCRs, al- 
lowing the development of CD8 + thymocytes that other- 
wise would not be observed (22, 23). CD4 has therefore also 
been implicated as having a signalling function in clonal de- 
letion. 
In earlier studies, we showed that the CDSc~ molecule  binds 
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tions  in  the  a3  domain that  prevented binding of CD8 
abrogated  the  ability of CD8 §  cytotoxic T  cells  to  lyse 
target cells. A naturally occurring human class I MHC mol- 
ecule, HLA-Aw68, was found to have a rare polymorphism 
in the c~3 domain that resulted in decreased binding of CD8 
(9).  T  cells restricted to interact with Aw68 were difficult 
to detect in some studies, raising the possibility that lack of 
interaction of CD8 and this class I molecule results in ineffident 
thymic positive selection of T cells having receptors  specific 
for Aw68 (24). To determine whether the interaction of CD8 
and class I MHC molecules is required, not only in activa- 
tion of mature T  cells, but also in developmental decisions 
during thymocyte maturation, we prepared transgenic mice 
expressing either wild-type class I molecules or mutant class 
I molecules deficient in CD8 binding. Analysis of T cell de- 
velopment in these animals indicates that the CD8-class I 
MHC interaction is essential both for positive selection and 
clonal deletion, and supports a model whereby CD8 serves 
as a coreceptor in these developmental processes. 
Materials  and Methods 
Transgenic Mice.  C57BL/6, C57BL/6xDBA/2 F1 and DBA/2 
mice were purchased from The Jackson Laboratory (Bar Harbor, 
ME)  and housed in  micro-isolator cages in  the  University of 
California, San Francisco transgenic  mouse facility.  The H-Y-specific 
TCR transgenic mouse (25) was from the breeding colony at the 
University of British Columbia. D  b transgenic mice were created 
and analyzed according to standard procedures (26). The 10-kb 
genomic fragment including the D  b gene (27) was obtained from 
Dr. Robert Goodenow, University of California, Berkeley, and a 
4.5-Kb XhoI/HindIII subclone  containing the c~3 domain was mu- 
tagenized (28) using the following oligo: 5'-acaagctccatcttctggg- 
tca-Y, which substitutes lysine for aspartic acid at residue 227. 
Purified 10-kb fragments containing either wild-type or mutant 
D b genes were microinjected  into C57BL/6  x  DBA/2 F2 zygotes. 
Founder mice were identified by Southern blot analysis of DNA 
from tail biopsies. F, mice, produced by back-crossing founders to 
DBA/2 animals, were mated to the H-Y/Db-specific TCR trans- 
genic mice  which had also  been similarly  back-crossed. Double trans- 
genic mice were identified by a combination of Southern blots on 
tail DNA and FACS  |  analysis  of PBNC using antibodies against 
the TCR-/~ chain, D b, and K  b (for the MHC background). 
Antibodies and Flow Cytometry.  H141-31  anti-D  b was purchased 
from Bioproducts for Science, Inc. (Indianapolis,  IN). AF6-88-5.3 
anti-K  8, and SF1-1.1.1 anti-K  a tissue culture supernatants were ob- 
tained from American Type Culture Collection (Rockville, MD) 
cell lines. Biotinylated antibodies against the transgenic TCR-a- 
(T3.70) and B (F23.1) chains  have  been previously  described  (29-31). 
PE-conjugated GK1.5 (PE-anti-L3T4), fluorescein-conjugated  53- 
6.7 (FITC anti-Lyt-2) and fluorescein  goat anti-mouse IgG (FITC- 
GAMIg) were obtained from Becton Dickinson & Co. (Mountain 
View, CA). Fhiorescein-conjugated  goat antiserum specific  for the 
Fc of mouse IgG was purchased from Jackson ImmunoResearch 
Laboratories, Inc. (West Grove, PA). A streptavidin tandem con- 
jugate of PE and Texas Red was obtained from Southern Biotech- 
nology (Birmingham, AL) or Gibco BRL (Grand Island, NY), 1-2 
x  106 cells were analyzed on a FACScan  |  flow cytometer (Becton 
Dickinson & Co.) using FACScan  |  or LYSYS II  |  software (Becton 
Dickinson & Co.). 
Cytotoxic T Cell Assays.  Secondary  CTLs were generated by 
culturing dendritic cells from male or female C57BL/6 mice with 
lymph node cells from female  C57BL/6 mice that had been primed 
with a single intraperitoneal injection of 2  x  107 male C57BL/6 
spleen cells for more than 14 d. Primed cells (5  x  106) were trans- 
ferred to 24-well plates containing dendritic cells (5  x  10s), in 
volumes of 2 ml of IMDM supplemented with 10% FCS, peni- 
cillin (100 U/ml), streptomycin (100 #g/ml), and 5  x  10 -5 M 
15-ME. After 5 d of  culture, six wells from each group were pooled 
and analyzed  for cytolytic activity against the indicated target cells 
in a 3-h SlCr-release assay. Target cells were prepared by culturing 
spleen cells in IMDM supplemented with Con A (2 #g/ml). 
For preparation of dendritic cells from two spleens, tissue was 
minced with scissors in 4 ml of PBS and pushed through a steel 
screen mesh. The screen was rinsed twice in 4 ml of PBS and the 
debris retained by the screen  was saved. Cells passing through the 
screen were further disaggregated by pipetting and pooled into a 
12-ml vol. Spleen cells were centrifuged, the supematant discarded, 
and the pellet  resuspended  by gentle mechanical  agitation. Red blood 
cells were lysed by addition of 0.5 ml of sterile water at 4~  for 
3 s followed  by 12 ml of PBS. Large aggregates of cell debris were 
removed  by sedimentation and the cell suspension centrifuged. The 
pellet was resuspended in IMDM, combined with debris retained 
by the screen described above, and plated in a single 100 x  15 mm 
petri plate (Cat. no. 8-757-12; Fisher Scientific Co., Pittsburgh, 
PA) in a total volume of 5 ml. Cells were incubated for 1-2 h at 
37~  The medium and large debris fragments  were gently decanted 
from the plates or withdrawn by pipette with minimal disturbance 
of the adherent cell lawn. 2 ml of IMDM at room temperature 
were added, and the plate was agitated vigorously by hand in a 
generally horizontal plane for 10-20 s. Care was taken to expose 
the perimeter of the plate to sufficient  turbulence to remove  loosely 
adherent B cells that had accumulated. This washing process was 
repeated three more times with a final rinse of 5 ml. Adherent cells 
were then cultured overnight at 37~  to permit detachment of 
dendritic cells which were harvested by pipetting. This procedure 
typically yielded 4-6  x  10  s cells per spleen equivalent, of which 
60-80% were dendritic cells as defined by expression of the 33D1 
surface marker (32). The vast majority of  contaminating cells were 
Ig + B cells as determined by surface staining with anti-mouse Ig 
FITC and FACS  |  analysis. 
Results 
Experimental  Strategy.  Mice expressing  transgenic TCR 
genes  provide a facile means of observing the processes  of 
positive and negative selection. One of the best characterized 
systems uses a transgenic TCR specific for the male antigen, 
H-Y, and the class I molecule H-2D  b (33).  In female mice 
that express the D b allele, thymocytes expressing the trans- 
genic  c~  and  B  chains  are  positively selected  to  become 
CD8 + cells (29).  In male animals that express D b, there is 
massive donal deletion that prevents  the accumulation of 
double positive cells and results in thymuses containing fewer 
than 10%  of the normal number of thymocytes (25). 
All T  cells in these mice express the transgenic TCK-~ 
chain and lack endogenous/~ chains, since the functionally 
rearranged transgenic TCR-I~ gene prevents expression of en- 
dogenous/~ genes (34). In contrast, expression of the TCR-o~ 
chain does not prevent the expression of endogenous ot genes, 
and the pairing of endogenous o~ chains with transgenic/~ 
chain can generate novel specificities. The transgenic t~ and 
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tively (29, 31, 35). In mice that  do not express the D b al- 
lele, development of thymocytes bearing the transgenic TCR-o~ 
and/3  chains  is arrested at  the double positive stage,  and 
progression to single positive mature cells  requires  surface 
expression of endogenous TCK-ot chain. Hence, mature cells 
in these mice have preferential pairing of transgenic fl chain 
with endogenous c~ chain  and,  consequently,  little surface 
expression of the transgenic  TCR-ot chain. 
To determine whether mutant  class I molecules that  do 
not bind CD8 can serve as substrates for positive and nega- 
tive selection in this system, we prepared transgenic mice ex- 
pressing  wild-type  or mutant  D b in  a  nonselecting  H-2  d 
background.  These mice were mated with the TCR trans- 
genic animals, and male and female offspring were analyzed 
for expression of the transgenes  and for the phenotype of 
the developing thymocytes. 
Generation of Transgenic Mice.  A  mutant  form  of the 
H-2D  b gene was produced by site-directed mutagenesis  at 
codon 227, substituting lysine for aspartic acid. Previous studies 
have shown that this mutation results in loss of CD8 binding 
and of the ability of this class I molecule to serve as a target 
for primary cytotoxic T cells (15, 36). Transgenic wild-type 
and mutant  D b were expressed at approximately  the same 
relative level on both thymocytes and peripheral lymphocytes, 
as judged by flow cytometry (Fig.  1). The level of expression 
on thymocytes was slightly higher than that of endogenous 
D b in C57BL/6 mice, but was roughly equivalent  to that 
of endogenous D d in DBA/2 mice (data not shown).  Ex- 
pression on peripheral  lymphocytes was equivalent  for the 
transgenes and the endogenous class I MHC molecules (Fig. 
1,  bottom). 
Lack of E.fflcient Negative Selection in Db-227/TCR  Tram- 
genie Mice.  CD4+CD8 +  thymocytes are  deleted  in  male 
H-2  b mice  that  express  the  H-Y-specific  transgenic  TCK 
(25). This situation is recreated in H-2  a mice transgenic for 
both the TCR and the wild-type D b molecule (Db-wt/TCR 
mice) (Fig. 2). The thymuses of these mice were diminished 
in size, lacked the usually predominant  CD4 +  CD8 § popu- 
lation,  and contained mostly CD4-CD8-  immature  cells. 
Deletion was dependent on the transgenic TCR,  as it was 
not observed in transgenic mice only expressing the Db-wt 
gene (data not shown). In contrast, a relatively normal pat- 
tern of thymocyte development was observed in H-2  a male 
mice expressing the transgenic  TCR and the D b molecule 
with a mutation  at residue 227 (Db-227/TCR mice) (Fig. 
2).  The  thymuses  of  these  mice  contained  a  prominent 
CD4+CD8 + population  and also the more mature  single 
positive CD8 + or CD4 ~ cells.  These latter cells expressed 
low levels of the transgenic TCR-c~ chain, probably because 
of its displacement by endogenous ol chains which would 
allow selection to occur through interaction with MHC mol- 
ecules other than D b. The capacity of D b to signal deletion 
does not appear to be completely abolished by the mutation 
at  227,  as  there  is  an  increase  in  the  number  of CD4-/ 
CD8-  thymocytes in some of these mice relative to H-2d/ 
TCR mice. This result may be due to some residual binding 
between Db-227 and CD8. 
The peripheral  lymphoid organs of male H-2  b mice that 
express the transgenic TCK were previously shown to con- 
tain a reduced complement of CD4 + cells, a CD8  l~ popula- 
tion,  and  a  significant  number  of CD4-CDS-  cells  ex- 
pressing  the  transgenic  TCR.  The  CD8 ]~  and  double 
negative cells are thought to escape deletion because they do 
not express high levels of CDS, but their natural physiolog- 
ical  counterparts  are  not  readily  identifiable.  The  D b- 
wt/TCK mice have this characteristic pattern of T  cells in 
their lymph nodes (Fig.  2, bottom). Some of the novel CD81~ 
and CD8-CD4-  cells are also observed to varying extents 
in the periphery of male Db-227/TCR  mice, probably be- 
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Figure 1.  Expression  of the transgenic MHC class I molecules on thymic and lymph node ceils. Thymocytes (top) and lymph node cells (bottom) 
were taken from DBA/2, C57BL/6, and from the two H-2  a transgenic lines expressing Db-wt and Db-227. Cells were stained with H141-31 (Anti-Db~ 
and SF1-1.1.1 (Anti-Kd), and detected with fluorescein goat anti-mouse IgG Fc. Each histogram represents 10,000 gated events analyzed on a FACScan  ~ 
flow cytometer (Becton Dickinson & Co.). 
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Figure 2.  FACS  |  analysis of thymic and lymph node cells from male transgenic mice. Thymocytes (tt) and lymph node cells (/3 and C) were taken 
from H-2  d TCR transgenic mice expressing either Db-wt, Db-227, or no D b (Db-Neg). Cells were stained with fluorescein anti-CDS, PE anti-CD4, 
and either F23.1-biotin or T3.70-biotin followed by streptavidin-tandem conjugate. Ten thousand events were analyzed on a FACScan  |  flow cytometer 
(Becton Dickinson & Co.).  (-4) Contour plot showing expression of CD4 and CD8 on thymocytes. (B) Contour plot showing expression of CD4 
and CD8 on lymph node T cells gated for expression of the transgenic B chain (F23.1 + T cells). (C) Histogram showing expression of the transgenic 
c~ (T3.70)  and 3  (F23.1) chains on CD8 + lymphocytes (gated within the rectangle in B). 
cause the mutation in class I MHC does not completely abolish 
deletion. However, there is substantial rescue of single posi- 
tive cells, which appear to express endogenous TCR-c~ chains 
in association with the transgenic B chain, as shown by the 
lack of significant staining with the c~ chain-spedfic antibody, 
T3.70.  Thus, the mutation in the CDS-binding site of the 
D b molecule significantly prevents clonal deletion, allowing 
the accumulation of double positive thymocytes that are then 
positively selected through their interaction with MHC mol- 
ecules other than D b expressed in the H-2  a mice. 
Lack of E.~cient Positive Selection in I~-227/TCR  Transgenic 
Mice.  To analyze the effect of loss of CD8 binding on posi- 
tive sdection of Db-restricted T  cells,  female animals ex- 
pressing the transgenic TCR and the wild-type or mutant 
class I transgenes were analyzed. As had been previously shown 
in female H-2  b mice (29),  animals expressing the wild-type 
D b transgene and the TCK transgene have a significant in- 
crease in the number of CD8 + thymocytes. All of these cells 
stain positively with the T3.70 antibody spedfic for the trans- 
genic ol chain, thus indicating that positive selection of T 
cells expressing the complete o~3 heterodimer had occurred 
(Fig.  3).  This  phenotype  is  not  observed in  female D b- 
227/TCR transgenic mice. The CD8/CD4 ratio in mature 
thymocytes in these animals is not significantly changed rel- 
ative to that in nonselecting H-2  d mice, and the CD8 § cells 
do not stain brightly with the T3.70 antibody as is seen in 
Db-wt/TCK mice. The Ds-227 molecule, therefore, fails to 
serve as an appropriate substrate for positive selection. 
The phenotype of T  cells in peripheral lymphoid organs 
is consistent with that observed in the thymus. Many CD8 + 
92  CD8-Class  I Interactions  in T  Cell Development Db-Neg 
A 
40~  LO 
0  3X 
CD8-FITC  ---> 
B 
30 
z 
0  ~  "V  ~'~" 
10 ~  1'01  1'0=  1'0  ~ 
Db-wt 
40X LO  I 
i 
11~.  77% 
2~.  10~. 
o  ,--- 
1 '04  1 o ~  1'o I  1'o=  1'o  ~  1'04 
Db-227 
q/ 
o  ~ 
~o  'i~,  "i~2 
40% Lo 
54~. 
....  i~ ..... r~. 
3O 
---F23.1 
-T3.70 
,.., 
_  --L 
O 10 ~  1'01  1'02  1'0  ~ 
Relative  Fluorescence  Intensity 
C 
n  ":: 65~. 
o 
~(~0 .....  1~  ~  ""i'~2  .....  i'~ ~"  ~'~ 
CD8-FITC  ---> 
D 30 ]  II 
~  , 
~  i 
I 
10 ~  1'01  1'0=  1'0  ~ 
1'04 
40~ 
JtS   ....  1 ~o"  "'"i~*:  .... 
t6~, 
40~.  Lc 
13~, 
30  i i  30 ]I  -"F23.1 
"  rl.; ..7~ 
, 
,  I 
1'o.  o  ,  o U  yE ~_  ~. 
10 ~  1'0 +  1'0  =  1'0  ~  104  10 ~  101  10  2  10  3 
Relative  Fluorescence  Intensity 
10 4 
Figure 3.  FACS  ~ analysis of thymic and lymph node cells from female transgenic mice. Thymocytes (A and B) and lymph node cells (C and D) 
were stained as in Fig. 2. (A) Contour plot showing expression of CD4 and CD8 on thymocytes. (B) Histogram showing expression of the transgenic 
(T3.70) and fl (F23.1) chains on CD8 + thymocytes (rectangle  in A). C and D are the same as A and B, but represent staining of total lymph node cells. 
ceils in the Db-wt/TCR mice express the transgenic TCR, 
although, unlike thymocytes, a significant proportion are 
TCR-oz  negative, possibly reflecting selective influences in 
the periphery. Few, if any, CD8 + T cells express significant 
levels of the transgenic TCR-~ chain in Db-227/TCR mice. 
Antigen Presentation by the Db-227 Molecule.  Both positive 
and negative selection are adversely affected by the substitu- 
tion of aspartic acid for lysine at residue 227. Based on previous 
studies which have shown that this residue is involved in 
binding of class I MHC to CD8, it is likely that the observed 
93  Killeen r  al. developmental defects are due to loss of this interaction. How- 
ever, these results could also be explained by a direct effect 
of the point mutation on the ability of D b to present the 
H-Y antigen. To address this issue, the ability of H-Y-specific 
cytotoxic T cells to lyse cells expressing wild-type and mu- 
tant D b was determined. Lymph node cells from C57BL/6 
female mice primed in vivo with syngeneic male cells and 
restimulated in vitro with male or female C57BL/6 dendritic 
cells were tested for their ability to lyse Con A blasts  from 
Db-wt and Db-227 mice. As shown in Fig. 4 (top), cells from 
male Db-227  mice were lysed by the secondary CTLs, but 
lysis was less ef~cient than that of Db-wt cells.  Specificity 
for H-Y was apparent because female cells neither provided 
stimulation for CTLs nor served as their targets. 
The antigen presentation function of Db-227 was further 
analyzed by a cold target competition experiment in which 
unlabeled cells were used to inhibit the lysis of labeled male 
Db-wt or male Db-227  target cells.  Lysis of Db-wt targets 
was most effectively inhibited by male Db-wt Con A blasts, 
but inhibition was also obtained with blasts from Db-227 
males, which were more e~cient than the female Db-wt or 
Db-227 cells (Fig. 4, bottom left).  In contrast, lysis of Db-227 
labeled targets was readily inhibited by blasts from either 
Db-wt or Db-227  male mice (Fig.  4,  bottom  right).  These 
results are consistent with the interpretation that two popu- 
lations comprised the secondary CTLs, one CDS-dependent, 
and  the other CD8-independent.  Lysis of Db-227  targets 
presumably involved only the latter population, whereas the 
Db-wt blasts could be lysed by either type of CTL. Overall, 
the results  indicate that  the Db-227  class  I  molecule can 
present H-Y antigen and is recognized by antigen-specific T 
cells. 
Discussion 
The importance of the interaction of CD8 with class I MHC 
molecules in T cell activation and development was predicted 
a decade ago after it was recognized that CD8 + ceils are re- 
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Figure 4.  P~cogllition of Db-wt 
and Db-227 by cytotoxic  T cells. 
('/bp) Lysis of stCr-hbded Con A 
bhsts from  male or female  Db-wt 
or  Db-227 transgenic mice by 
secondary  CTLs. (Bottom)  Inhibi- 
tion of lysis of s:Cr-labded male 
Db-wt or Db-227 Con A blasts 
by unlabeled  male or female  Con 
A blasts. 
stricted to interact with class I MHC molecules (37). Subse- 
quent studies have demonstrated a direct physical interaction 
between CD8 and class I MHC molecules (8, 38), and a re- 
quirement for CD8 expression in the function of class I-specific 
T cells (39). Results of studies with mice lacking expression 
of either CD8 (20) or of class I MHC (40, 41), and the demon- 
stration that injection of anti-CD8 antibodies into mice blocks 
development of CD8 +  class  I-restricted cells,  but  not  of 
CD4 + class II-restricted cells (18,  19),  strongly suggested 
that the interaction of CD8 and class I molecules is required 
in development. However, these experiments did not con- 
clusively establish that the observed developmental defects 
were solely due to abrogation of this interaction. 
In this study, we have analyzed the consequences of dis- 
rupting the CD8-class I interaction on positive and negative 
selection of thymocytes expressing a well-characterized TCR. 
The disruption was achieved by introducing a mutation at 
residue 227  in the ol3 domain of the class I molecule D b. 
This mutation has previously been shown to prevent binding 
to CD8ol  and to result in loss of recognition by primary, 
but not secondary, cytotoxic cells (15,  36). Residue 227  is 
located in a hydrophilic, solvent-exposed loop of the c~3 do- 
main, and its substitution is unlikely to result in significant 
changes in the conformation of the class I molecule (15). 
Moreover, cells from male mice that express the mutant mol- 
ecule are effectively lysed by secondary CTLs  specific for 
H-Y/D  b, indicating that the antigen-presenting function of 
the molecule is not significantly impaired. Subtle effects on 
peptide presentation may still exist, but in the absence of struc- 
tural data,  this issue is dif~cult to resolve. 
Although the mutant D b molecule can be recognized by 
the specific TCR,  its inability to bind CD8 was found to 
result in significant impairment in both positive and nega- 
tive selection of thymocytes expressing the receptor. Dele- 
tion of autoreactive cells in male mice that express the trans- 
genic H-Y/Db-specific receptor is dramatically reduced in the 
context  of the  mutant  D b molecule,  and  the  pattern  of 
thymocyte development resembles that seen in the absence 
of a deleting MHC structure. However, some of the Db-227 
mice showed a variable increase in the number of CD4- 8- 
thymocytes, perhaps reflecting reductions in the other subsets 
Thymic Mlcroenvironment 
Thymocyte 
|  | 
..p~,.. h,..~.. |  Q 
Figure 5.  Model  for the coreceptor  function of CD8 in the develop- 
ment of thymocytes.  The diagram represents  thymocyte  development  in 
the presence of Db-wt or Db-227. 
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example  of this,  and  has  35%  CD4-CD8-  thymocytes 
compared with 7% in the mouse that does not express D b. 
Other  Db-227  mice were indistinguishable  from the D b- 
negative mice in their CD4/CD8 staining profiles.  The pe- 
ripheral T  cells  of male Db-227/TCK  mice include many 
more single positive cells than those of Db-wt/TCK mice. 
In particular, the CD4+8 -  subset is largely rescued by the 
mutation. However, there were also a substantial number of 
CD8  l~ and CD4- CD8-  cells in some male mice bearing the 
mutant class I molecule. These cells dominate the periphery 
of male H-2b/TCK (35) and Db-wt/TCK transgenic mice. 
Recent data suggest that exit of these cells from the thymus 
does not depend on positive selection (42).  The appearance 
of these cells in Db-227/TCK  mice may be a consequence 
of partial deletion due to residual binding between the mu- 
tant class I molecule and CD8.  This possibility is difficult 
to evaluate since the physiologically active threshold for binding 
has not been adequately determined using in vitro assays. Al- 
ternatively, these cells may represent a distinct lineage that 
is independent ofCD8-dass I interaction and that may have 
a selective  advantage in a male D b environment. Nonethe- 
less, it is clear that the capacity of wild-type D b to mediate 
clonal deletion of self-reactive  thymocytes in male mice is 
largely abrogated by a mutation in the CD8 binding region. 
In female Db-227  mice, positive selection of CD8 + cells 
bearing both chains of the transgenic TCK is not detectable. 
Thus, the progression of thymocytes to CD8 + T  cells ap- 
pears to require the binding of CD8 to the class I MHC mol- 
ecule. This result is consistent with the findings of Ziljstra 
et al. (40) and Fung-Leung et al. (20), showing that develop- 
ment of the CD8 lineage does not occur in the absence of 
expression of class I MHC or CDS. In addition, it provides 
a likely explanation for the relative paucity of HLA-Aw68-reac- 
tive T  cells in humans. A polymorphism at residue 245 in 
the c~3 domain of this molecule results in decreased binding 
to CD8 and, hence, is likely to prevent positive selection of 
thymocytes reactive with Aw68. 
The results presented here are consistent with the conclu- 
sions of two recent reports describing transgenic MHC class 
I molecules bearing analogous c~3 domain mutations. These 
were shown to be inefficient in deleting CD8 + cells specific 
for allo-dcterminants expressed on the same molecules (43, 
44).  Positive  sdection of Ld-restricted T  ceils specific for a 
murine cytomegalovirus peptide was also absent in one of 
the transgenic lines (43). 
The  D b  transgenic  mice  used  in  this  analysis  express 
normal H-2  d MHC class I molecules with unmodified c~3 
domains. As depicted in Fig. 5, these molecules could theo- 
retically participate in thymocyte development by providing 
unimpeded CD8 interactions to accompany TCK recogni- 
tion of H-Y/Db-227. The fact that this type of complemen- 
tation is unable to rescue either positive or negative sdection 
indicates a requirement for coordinate recognition of a single 
MHC class I molecule by a complex of the TCK and CD8. 
A similar conclusion has been reached from the lack of target 
cell lysis by CTLs recognizing class I molecules that do not 
bind CD8 (15, 16, 45). These experiments showed that CD8 
binding sites on other class I molecules could not substitute 
for the defective site on the molecule presenting antigen to 
the TCK. The lack of positive and negative sdection in D b- 
227 mice now provides in vivo evidence for the model of 
CD8  as a coreceptor in T  cell recognition of antigen. 
The initial description of TCK transgenic mice established 
that TCK specificity determines the CD4/CD8 phenotype 
of the developing T cell. For example, TCR transgenes iso- 
lated from a class I-restricted T  cell done cause preferential 
development of CD8 + T  cells in mice that express the ap- 
propriate  MHC  class  I  allele  (29,  46,  47).  The  same 
phenomenon has been observed for class II-restricted TCKs 
and CD4 + T  cells (48, 49).  The analysis  of Db-227/TCK 
mice has demonstrated the active participation of the CD8 
coreceptor in the determination of the CD8 lineage. While 
the function of CD8 appears  to require binding to MHC 
class I, its signaling role in thymocytes remains poorly un- 
derstood. Both CD8a and CD4 bind to the cytoplasmic tyro- 
sine kinase p56 ~k through cysteine residues in  their cyto- 
plasmic tails (11, 12). This interaction is required for efficient 
in vitro T cell activation in coreceptor-dependent systems (13, 
14). It remains to be determined whether the association of 
CD8ot with p56  ~k has a significant role in thymic differen- 
tiation and whether distinct signals are mediated by the CD4 
and CD8 coreceptors. 
We are grateful to Soo-Jeet Teh for expert technical assistance and to Kathy Smith for help in the initial 
phase of this work. We thank Thomas Jenuwein for providing instruction in transgenic techniques, and 
Craig Davis, Art Weiss, Peter Parham, and Anne Norment for their advice and helpful discussions. 
This work was supported by a long-term fellowship from the European Molecular Biology Organization 
to N. Killeen, by a grant from the Canadian Medical Research Council to H.-S. Teh, and by a grant 
from the National Institutes of Health (RO1 AI23513) to D. K. Littman. D. g. Littman is an investigator 
of the Howard Hughes Medical Institute. 
Address correspondence to Dr. Dan K. Littman, Department of Microbiology and Immunology, Howard 
Hughes Medical Institute,  University of California, San Francisco, CA 94143--0414. 
Received for publication 24 February 1992 and in revised  form 9 April 1992. 
95  Killccn et al. References 
1.  von Boehmer, H., H.-S. Teh, and P. Kisielow. 1989. The thymus 
selects the useful, neglects the useless and destroys the harmful. 
Immunol.  Today. 10:57. 
2.  Ashwell, J.D., and K.D. Klausner.  1990. Genetic and muta- 
tional analysis of the T-cell antigen receptor. Annu.  Rev. Im- 
munol. 8:139. 
3.  Turner, J.M., and D.R. Littman. 1991. Function of CD4 and 
CD8 in T cell activation and differentiation. In Advances in 
Regulation of Cell Growth, Vol. 2. J. Mond, A. Weiss, and 
J. Cambier, editors. Raven  Press,  New York.  10:645. 
4. Janeway, C.A., Jr. 1992. The T cell receptor as a multicompo- 
nent signalling  machine. Annu.  Rev. Immunol.  10:645. 
5.  Littman, D.R. 1987. The structure of the CD4 and CD8 genes. 
Annu.  Rev. Immunol. 5:561. 
6.  Parnes, J.R.  1989.  Molecular biology and function of CD4 
and CDS. Adv. Immunol. 44:265. 
7.  Doyle, C., andJ.L. Strominger. 1987. Interaction between CD4 
and class II MHC molecules mediates  cell adhesion.  Nature 
(Lond.). 330:256. 
8.  Norment, A.M., K.D. Salter, P. Parham, V.H. Engelhard, and 
D.K. Littman. 1988. Cell-cell adhesion mediated by CD8 and 
MHC class I molecules.  Nature (Lond.). 336:79. 
9.  Salter, R.D., A.M. Norment, B.P. Chen, C. Clayberger, A.M. 
Krensky, D.R. Littman, and P. Parham. 1989. Polymorphism 
in the alpha 3 domain of HLA-A molecules affects binding to 
CDS. Nature (Lond.). 338:345. 
10.  Rudd, C.E., J.M. Trevillyan, J.D. Dasgupta, L.L. Wong, and 
S.F. Schlossman.  1988. The CD4 receptor is complexed in de- 
tergent lysates to a protein-tyrosine kinase (pp58) from human 
T  lymphocytes. Proc. Natl.  A_cad. Sci. USA.  85:5190. 
11.  Shaw, A.S.,  K.E. Amrein, C.  Hammond, D.F. Stern, B.M. 
Sefton, and J.K. Rose. 1989. The lck tyrosine protein kinase 
interacts with the cytoplasmic tail of the CD4 glycoprotein 
through its unique amino-terminal domain.  Cell. 59:627. 
12.  Turner, J.M., M.H. Brodsky, B.A. Irving, S.D. Levin, R.M. 
Perlmutter, and D.K. Littman. 1990. Interaction of the unique 
N-terminal region of tyrosine kinase p56  ~k with cytoplasmic 
domains of CD4 and CD8 is mediated by cysteine motifs. Cell. 
60:755. 
13.  Zamoyska, R., P. Derham, S.D. Gorman, P. von Hoegen, J.B. 
Bolen, A. Veillette, and J.R. Parnes.  1989. Inability of CD8 
alpha' polypeptides  to associate with p56  ~k correlates with im- 
paired function in vitro and lack of expression in vivo. Nature 
(Lond.). 342:278. 
14.  Glaichenhaus,  N., N. Shastri, D.R. Littman, andJ.M. Turner. 
1991.  Requirement  for association  of p56  ~k  with  CD4  in 
antigen-specific  signal  transduction in T  cells. Cell. 64:511. 
15.  Salter, R.D., R.J. Benjamin, P.K. Wesley, S.E. Buxton, T.P. 
Garrett, C. Clayberger,  A.M. Krensky, A.M. Norment, D.R. 
Littman, and P. Parham.  1990. A binding site for the T-cell 
co-receptor CD8 on the alpha 3 domain of HLA-A2. Nature 
(Lond.). 345:41. 
16.  Connolly, J.M., T.H. Hansen, A.L. Ingold, and T.A. Potter. 
1990. Recognition by CD8 on cytotoxic T lymphocytes is ab- 
lated by several substitutions in the class I alpha 3 domain: 
CD8 and the T-cell receptor recognize the same class I mole- 
cule. Pro~ Natl.  Acad. Sci. USA.  87:2137. 
17. Janeway, C.A., Jr. 1989. The role of CD4 in T-ceU activation: 
accessory molecule or co-receptor? Immunol.  Today. 10:234. 
18.  Ramsdell, F., and B.J. Fowlkes.  1989. Engagement of CD4 
and CD8 accessory molecules is required for T  cell matura- 
tion. J. Immunol. 143:1467. 
19.  Zuniga-Pflucker, J.C., L.A. Jones, D.L. Longo, and A.M. Krnis- 
beek.  1990.  CD8  is  required  during  positive  selection  of 
CD4-/CD8 + T  cells. J. Extz Med. 171:427. 
20.  Fung-Leung,  W.P.,  M.W.  Schilham,  A.  Rahemtulla,  T.M. 
Kundig, M. Vollenweider, J. Potter, W. van Ewijk, and T.W. 
Mak. 1991. CD8 is needed for development ofcytotoxic T cells 
but not helper T  cells. Cell. 65:443. 
21.  Rahemtulla,  A.,  W.P.  Fung-Leung,  M.W.  Schilham,  T.M. 
Kundig,  S.R.  Sambhara,  A.  Narendran,  A.  Arabian,  A. 
Wakeham, C.J. Paige, R.M. Zinkernagel et al. 1991. Normal 
development and function of CD8 + ceils but markedly de- 
creased helper cell activity in mice lacking CD4. Nature (Lond.). 
353:180. 
22.  Fowlkes, B.J., R.H. Schwartz, and D.M. Pardoll. 1988. Dele- 
tion of self-reactive thymocytes occurs at a CD4+8 + precursor 
stage. Nature (Lond.). 334:620. 
23.  MacDonald, H.R., H. Hengartner, and T. Pedrazzini. 1988. 
Intrathymic deletion of self-reactive cells prevented by neonatal 
anti-CD4 antibody treatment. Nature (Lond.). 335:174. 
24.  Parham,  P.  1989.  Getting into  the  groove.  Nature (Lond.). 
342:617. 
25.  Kisielow, P., H. Bluthmann, U.D. Staerz, M. Steinmetz, and 
H. yon Boehmer. 1988. Tolerance in T-cell-receptor transgenic 
mice involves deletion of nonmature CD4+8 + thymocytes. 
Nature (Lond.). 333:742. 
26.  Hogan, B.L.M., F. Costantini, and E. Lacy. 1986. Manipulating 
the Mouse Embryo. A Laboratory Manual. Cold Spring Harbor 
Laboratory Press, Cold Spring Harbor, NY. 
27.  Watts, S., J.M. Vogel, W.D. Harriman, T. Itoh, HJ. Strauss, 
and R.S. Goodenow. 1987. DNA sequence analysis of the C3H 
H-2K  k and  H-2D  k loci.  Evolutionary relationships  to H-2 
genes  from four other mouse strains. J. Immunol. 139:3878. 
28.  Kunkel, T.A. 1985. Rapid and efficient site-specific mutagen- 
esis without phenotype selection.  Proc. Natl. Acad. Sci. USA. 
82:488. 
29.  Teh, H.-S., P. Kisielow, B. Scott, H. Kishi, Y. Uematsu, H. 
Bluthmann,  and  H.  yon  Boehmer.  1988.  Thymic  major 
histocompatibility complex antigens and the alpha beta T-cell 
receptor determine the CD4/CD8 phenotype of T cells. Na- 
ture (Lond.). 335:229. 
30.  Teh,  H.-S.,  H.  Kishi,  B.  Scott,  H.  von  Boehmer,  and  P. 
Kisielow.  1990. Early deletion and late positive selection  of 
T cells expressing a male-specific receptor in T  cell receptor 
transgenic mice.  Dev. Immunol.  1:1. 
31.  Staerz,  U.D.,  H.G.  Rammensee, J.D.  Benedetto, and M.J. 
Bevan. 1985. Characterization of a murine monoclonal anti- 
body specific for an allotype determinant on T  cell antigen 
receptor. J. Immunol.  134:3994. 
32.  Nussenzweig, M.C., K.M. Steinman, M.D. Witmer, and B.A. 
Gutchinov. 1982. A monoclonal antibody specific for mouse 
dendritic cells. Pro~ Natl. Acad. Sci. USA.  79:161. 
33.  yon Boehmer, H. 1990. Developmental biology of T cells in 
T  cell receptor transgenic mice. Annu. Rev. Immunol. 8:531. 
34.  Uematsu, Y., S. Ryser, Z. Dembic, P. Borgula, P. Krimpen- 
fort, A. Berns, H. yon Boehmer, and M. Steinmetz. 1988. In 
transgenic mice the introduced functional T cell receptor beta 
gene prevents expression of  endogenous beta genes. Cell. 52:831. 
35.  Teh, H.-S., H. Kishi, B. Scott, and H. Von Boehmer. 1989. 
Deletion of autospecific T cells in T cell receptor (TCR) trans- 
genic mice spares cells with normal TCR levels and low levels 
96  CD8-Class  I Interactions in T Cell Development of CD8 molecules. J. Ext~  Med.  169:795. 
36.  Potter, T.A., T.V. Rajah, R.F. Dick 2nd., andJ.A. Bluestone. 
1989.  Substitution at residue 227 of H-2 class I  molecules 
abrogates  recognition  by  CD8-dependent,  but  not  CD8- 
independent, cytotoxic T lymphocytes. Nature (Lomt.). 337:73. 
37.  Swain, S.L. 1981. Significance of Lyt phenotypes: Lyt-2 anti- 
bodies block activities of T cells that recognize class I major 
histocompatibility complex antigens regardless of their func- 
tion. Pro~ Natl. Acad. Sci. USA.  78:7101. 
38.  Rosenstein, Y., S. Ratnofsky, S.J. Burakoff, and S.H. Herr- 
mann. 1989. Direct evidence for binding of CD8 to HLA class 
I antigens. J. Extx Med.  169:149. 
39.  Gabert,  J.,  C.  Langlet,  R.  Zamoyska,  J.R.  Parnes,  A.M. 
Schmitt-Verhulst,  and B. Malissen.  1987.  Reconstitution of 
MHC class I specificity by transfer of the T cell receptor and 
Lyt-2 genes.  Cell.  50:545. 
40.  Zijlstra, M., M. Bix, N.E. Simister, J.M. Loring, D.H. Raulet, 
and R. Jaenisch. 1990. Beta-2-microglobulin deficient mice lack 
CD4-8 + cytolytic T  cells. Nature (Lond.). 344:742. 
41.  KoUer, B.H., P. Marrack, J.W. Kappler, and O. Smithies. 1990. 
Normal development of mice deficient in beta 2m, MHC class 
I proteins, and CD8 + T cells. Science (Wash. DC).  248:1227. 
42.  yon Boehmer, H., J. Kirberg, and B. Rocha. 1991. An unusual 
lineage of a/B T cells that contains autoreactive cells.J. Exp. 
Med.  174:1001. 
43.  Aldrich, C.J., R.E. Hammer, S. Jones-Youngblood, U. Kos- 
zinowski, L. Hood, I. Stroynowski, andJ. Forman. 1991. Nega- 
tive and positive selection of antigen-specific  cytotoxic T lym- 
phocytes affected by the alpha 3 domain of MHC I molecules. 
Nature (Lond.). 352:718. 
44.  Ingold, A.L., C. l.andel, C. Knall, G.A. Evans, and T.A. Potter. 
1991. Co-engagement of CD8 with the T cell receptor is re- 
quired for negative selection.  Nature (Lond.). 352:721. 
45.  Kalinke, U., B. Arnold, and G.J. Hammerling. 1990. Strong 
xenogeneic HLA response in transgenic mice after introducing 
an alpha 3 domain into HLA B27. Nature (Lond.). 348:642. 
46.  Sha, W.C., C.A. Nelson, K.D. Newberry, D.M. Kranz, J.H. 
Russell,  and D.Y. Loh. 1988. Positive and negative selection 
of an antigen receptor on T cells in transgenic mice. Nature 
(Lond.). 336:73. 
47.  Sha, W.C., C.A. Nelson, R.D. Newberry, D.M. Kranz, J.H. 
Russell, and D.Y. Loh. 1988. Selective expression of an antigen 
receptor on CDS-bearing T lymphocytes in transgenic mice. 
Nature (Lond.). 335:271. 
48.  Berg, L.J., A.M. PuUen, B. Fazekas de St. Groth, D. Mathis, 
C. Benoist, and M.M. Davis.  1989. Antigen/MHC-specific 
T cells are preferentially exported from the thymus in the pres- 
ence of their MHC ligand. Cell.  58:1035. 
49.  Kaye, J., M.L. Hsu, M.E. Sauron, S.C. Jameson, N.K. Gas- 
coigne,  and  S.M.  Hedrick.  1989.  Selective  development of 
CD4 + T cells in transgenic mice expressing a class II MHC- 
restricted antigen receptor. Nature (Lond.). 341:746. 
97  Killeen  et  al. 